Ferraioli, M.; Aiello, A.; Prevete, I.; Chimenti, M.S.; De Marco, L.; Meschi, S.; Mariotti, D.; Vanini, V.; Cuzzi, G.; Salmi, A.;
et al. Anti-SARS-CoV-2 B and T-Cell Immune Responses Persist 12 Months After mRNA Vaccination with BNT162b2 in Systemic Lupus Erythematosus Patients Independently of Immunosuppressive Therapies. Vaccines 2025, 13, 396.
https://doi.org/10.3390/vaccines13040396
AMA Style
Ferraioli M, Aiello A, Prevete I, Chimenti MS, De Marco L, Meschi S, Mariotti D, Vanini V, Cuzzi G, Salmi A,
et al. Anti-SARS-CoV-2 B and T-Cell Immune Responses Persist 12 Months After mRNA Vaccination with BNT162b2 in Systemic Lupus Erythematosus Patients Independently of Immunosuppressive Therapies. Vaccines. 2025; 13(4):396.
https://doi.org/10.3390/vaccines13040396
Chicago/Turabian Style
Ferraioli, Mario, Alessandra Aiello, Immacolata Prevete, Maria Sole Chimenti, Luigi De Marco, Silvia Meschi, Davide Mariotti, Valentina Vanini, Gilda Cuzzi, Andrea Salmi,
and et al. 2025. "Anti-SARS-CoV-2 B and T-Cell Immune Responses Persist 12 Months After mRNA Vaccination with BNT162b2 in Systemic Lupus Erythematosus Patients Independently of Immunosuppressive Therapies" Vaccines 13, no. 4: 396.
https://doi.org/10.3390/vaccines13040396
APA Style
Ferraioli, M., Aiello, A., Prevete, I., Chimenti, M. S., De Marco, L., Meschi, S., Mariotti, D., Vanini, V., Cuzzi, G., Salmi, A., Notari, S., Mellini, V., Puro, V., Maggi, F., Goletti, D., & Sebastiani, G. D.
(2025). Anti-SARS-CoV-2 B and T-Cell Immune Responses Persist 12 Months After mRNA Vaccination with BNT162b2 in Systemic Lupus Erythematosus Patients Independently of Immunosuppressive Therapies. Vaccines, 13(4), 396.
https://doi.org/10.3390/vaccines13040396
